For context, weight loss outcomes in trials of currently licensed treatments include approximately 15% with semaglutide 2.4 mg (STEP 1 trial, Wilding et al., NEJM 2021) and approximately 2022% with tirzepatide (SURMOUNT-1 trial, Jastreboff et al., NEJM 2022)
It is a view that many in the alt-right share
Diabetes 72 , 599610 (2023)
The benzyl alcohol works by slowing bacterial growth rather than killing bacteria outright, which makes it suitable for repeated use as long as proper aseptic techniques are followed
Obesity Prevalence and 2035 Projections In 1990, roughly 1 in 5 American adults had obesity
For recurrent injection site reactions that occur with every dose, schedule a non-urgent appointment with your healthcare provider or diabetes care and education specialist (CDCES)